Allerpops

Suffering from allergies? Eat some candy.

That’s the premise behind AllerPops, a consumer-health company that’s created an oral medication that resembles a lollipop and is designed to address the root cause of allergies. In a recent survey, more than ninety-four percent of users said this product was effective at relieving allergies.

Allergy relief is a forty-billion-dollar global market. Fifty million Americans suffer from airborne allergies alone. AllerPops’ product is protected by six patents and the company is generating revenue.

Team Background

Cliff Han - Founder & CEO

Paul Scott - Chief Marketing Officer

Co-Investors